Many inflammatory biomarkers, such as interleukin (IL)-2, IL-6, IL-10 and tumor necrosis factor, were found higher in COVID-19 patients with severe disease, compared with those with mild or moderate disease [52]. The gene discussed is IL6; the disease is COVID-19.